Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Grades Itself Highly In Reports On Safety Of Imported Products And Marketed Drugs

Apr 24 2012

• By Brenda Sandburg

Related Content

Sabril's Approval With REMS No Surprise, But May Provide Marketing Advantage

Aug 21 2009

FDA’s Globalization Strategy Needs To Be More Aggressive, Sen. Brown Suggests

Apr 20 2012

FDA Looks To Capitol Hill For New Authority For Globalization Plan

Jun 20 2011

Related Companies

GSK plc

Takeda Pharmaceutical Co. Ltd.

Additional Topics

United States Regulation Post Market Regulation & Studies Safety BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window